Abstract
Cutaneous melanoma includes a heterogeneous subset of malignant melanocytic proliferations that differ significantly in their epidemiology, morphology, growth dynamics, genetics, and clinical behavior. Reflectance confocal microscopy (RCM) is well suited to image melanocytic lesions because melanin acts as a naturally occurring “endogenous” contrast. RCM evaluation has the potential to increase sensitivity (improves melanoma detection) and specificity (reduces excisions of benign lesions) for melanoma. In fact, the use of RCM allows to highlight useful microscopic features.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
In the recent years, we are observing an increase in the incidence of melanoma worldwide. Although increased awareness of melanoma has led to more efficient screening and improved understanding of melanoma tumorigenesis has guided the development of new therapeutic options, melanoma still carries significant morbidity and mortality. As many other cancers, early diagnosis and prompt surgical excision are essential. Early detection necessarily implied the development of new noninvasive diagnostic techniques. Reflectance confocal microscopy (RCM) allows dynamic imaging of the skin at cellular resolution in real time, performing optical biopsies [1,2,3]. Microscopic tissue elements reflect light with different refractive indices. RCM is particularly useful for imaging melanocytic lesions, such as nevi or melanoma [4, 5], because melanin has the highest refractive index of all tissue elements (n = 1.7) and acts as a naturally occurring “endogenous” contrast [4]. Several studies have demonstrated that RCM evaluation has the potential to increase sensitivity (improves melanoma detection) [6, 7] and specificity (reduces excisions of benign lesions) for melanoma [8,9,10,11].
1 RCM Features According to Melanoma Subtype
The term cutaneous melanoma includes a heterogeneous subset of malignant melanocytic proliferations that differ significantly in their epidemiology, morphology, growth dynamics, and clinical behavior. Four major histological subtypes of melanoma have been described: superficial spreading melanoma (SSM), nodular melanoma (NM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM). Less common melanoma subtypes include nevoid melanoma, desmoplastic melanoma, clear cell sarcoma, and solitary dermal melanoma.
1.1 Superficial Spreading Melanoma
SSM is the most common melanoma subtype (50–80% of all melanoma diagnoses) (Figs. 14.1, 14.2). The name is derived from a prolonged radial (lateral) growth phase before invasive (vertical) growth starts. Although it can develop in any anatomic location, it most likely occurs on sun-exposed areas such as the back in men and the lower limbs in women. Few melanomas can arise from a precursor nevus and mostly occur de novo. SSM is characterized histologically by pagetoid spread and nests of the epithelioid melanocytes at the dermo–epidermal junction (DEJ). Poor circumscription with variable epidermal thickening is also common. Cytologically, melanocytes may have one or more large nuclei with an abundant cytoplasm that is often amphophilic, eosinophilic, or finely pigmented with melanin granules.
RCM criteria vary according to the examined skin layer (Table 14.1) [12]. Pagetoid spread is well visible in the epidermis (Fig. 14.1c–e). Notably, pagetoid cells appear as large hyper-reflective nucleated cells in SSM. These melanocytes are mostly rounded with variably short and thick dendrites. Additionally, dendritic melanocytes could be detected, although this melanoma subtype is mainly characterized by the presence of roundish atypical melanocytes [13]. By definition, pagetoid cells under RCM have a large size (they are larger than the surrounding keratinocytes) and are scattered within the suprabasal epidermal layers without any cell connection with the neighboring keratinocytes, giving the impression of floating cells. In situ melanomas present few or localized pagetoid cells compared with invasive tumors in which a florid pagetoid infiltration could be detected in the entire melanoma and at all epidermal layers, even in the stratum corneum [13]. The presence of atypical melanocytes can subvert the typical epidermal architecture, leading to the loss of the normal honeycomb or cobblestone pattern. Under RCM, three main tumor architectures can be detected at the DEJ: irregular ringed, irregular meshwork, and irregular clod, as well as variable combinations of all of them [13]. Furthermore, many tumors might not display any of those but rather a nonspecific pattern: dermal papillae are not clearly visible or not well demarcated by a normal rim of bright cell but rather by large reflective cells corresponding to malignant melanocytes (loss of the normal-edged dermal papillae, Figs. 14.1f and 14.2c, d). In more advanced cases, the DEJ is totally disarranged by the melanocytic proliferation. Distinct nest types can be observed according to the growth phase of the tumor: dense nests are found in early phase, whereas dense and sparse and sheet-like structures are typical of the dermal invasion [13].
1.2 Nodular Melanoma
NM has a fast growth rate and is associated with a higher rate of death [14]. Amelanotic or hypomelanotic presentation of NM is particularly challenging [15] and can be mistaken for benign tumors. At RCM (Table 14.2), NM reveals a thinned epidermis (epidermal consumption) with the typical epidermal architecture still recognizable and few pagetoid cells [16]. The DEJ is completely disrupted, and the dermal compartment is filled with a solid proliferation of melanocytes with variable shape and size arranged as single cells or clustered. The so-called sheet-like structures that represent a proliferation of dyscohesive atypical melanocytes with prominent nuclei are frequent in NM. Remarkably, melanocytic nests with cerebriform appearance (cerebriform nests) are specific of NM and melanoma skin metastasis. Those nests show up as dark hyporeflective clusters of melanocytes that are outlined by brighter collagen fibers. Enlarged and tortuous vessels can also be frequently found. Tumor clusters are commonly found in proximity to these newly formed vessels [12].
1.3 Lentigo Maligna and Lentigo Maligna Melanoma
Lentigo maligna (LM) presents as a slowly progressive pigmented macule on sun-exposed areas, most commonly on the face (Figs. 14.3a and 14.4a) and neck, and LMM is its invasive counterpart. Its clinical diagnosis is often challenging because it shows overlapping features with benign lesions. As it is often large and located on esthetic and functional areas, noninvasive imaging techniques such as dermoscopy and RCM are of great interest for its diagnosis. Dermoscopy has improved the diagnosis of LM/LMM, but they remain a challenge owing to overlapping features with solar lentigo, pigmented actinic keratosis, and lichenoid keratosis (Figs. 14.3b and 14.4b) [17, 18]. Histopathology could also be of difficult interpretation due to atypical melanocytic proliferation on sun-damaged skin [19]. RCM has proved to be helpful to enhance diagnosis of LM/LMM. Features of LM/LMM using RCM are well described [20,21,22,23,24,25] (Table 14.3). The earliest histopathological finding in LM is the proliferation of atypical melanocytes at the DEJ [26] that correlate with large hyper-reflective polymorphic cells under RCM (Figs. 14.3c and 14.4c, d). Numerous large pagetoid cells and consequent epidermal disarray are subsequently found. In LM/LMM, atypical melanocytes are more often dendritic than roundish and are typically located around and inside hair follicles (Figs. 14.3c and 14.4c, d). In some cases, only numerous hyper-reflective dendrites are visible, and not cell bodies and these hyper-reflective long dendrites form “medusa head-like structures” (Fig. 14.3c) around hair follicles. Advanced cases show large nucleated cells organized in nests in the upper dermis [12].
1.4 Acral Lentiginous Melanoma
The clinical and histological diagnosis of ALM may be very difficult, especially in the early phase of growth. Palms and soles are rarely studied by RCM because of the increased thickness of the epidermis that hampers the visualization of deeper layers. However, RCM can also be useful in acral site because early ALM is characterized by a lentiginous spread [27], and the epidermal thickness of acral areas is variable.
Pagetoid cells are the predominant clue for suspecting ALM by RCM [28]. The pagetoid spread of melanocytes also determines a disarrangement of the normal honeycomb pattern of the epidermis. Noteworthy in case of a thick stratum corneum, a skin scraping could allow to identify pagetoid cells in the epidermis that are at first not visible. It should be noticed that a proliferation of solitary arranged melanocytes can also be detected within the epidermis of melanocytic acral nevus with intra-epidermal ascent (MANIACs) [29]. However, pagetoid cells in these cases are monomorphous [28].
A characteristic feature of ALMs is the infiltration of sweat duct structures by atypical bright cells that correspond to a melanocytic extension along adnexal structures in histology. Nevi show more rarely a melanocytic proliferation around sweet duct structures and in these cases, melanocytes are mainly organized in nests [28, 30]. Another peculiar feature of ALM is the higher presence of granular dust-like hyper-reflective particles in the epidermis compared to nevi, possibly corresponding to free pigment. Free pigment is randomly distributed in ALMs and tends to be arranged in columns in the furrows in nevi [30].
In all ALMs with a visible dermis, sheets and/or nests of large atypical cells are usually seen, whereas these features are never found in nevi [28]. However, ALM diagnosis cannot be excluded in the absence of RCM signs because early ALM can present only subtle atypia such as slight proliferation of atypical melanocytes at the DEJ that may not be identified under RCM [28].
1.5 Desmoplastic Melanoma
Desmoplastic melanoma is a rare melanoma subtype that most commonly occurs on chronically sun-exposed areas of elderly patients. Misdiagnosis is common as it is often amelanotic and may mimic a scar or benign cutaneous tumor, such as dermatofibroma [31]. This melanoma is characterized by bundles of spindle-shaped melanocytes admixed with dense collagen and patchy lymphoid infiltrate in the dermis. These cells have a fibroblast-like appearance but hyperchromatic and bizarre nuclei are visible. The junctional component is minimal.
RCM features that may suggest the diagnosis of desmoplastic melanoma in the upper dermis are spindle melanocytes (elongated hyper-reflective large and often nucleated cells) and inflammation (presence of small hyper-reflective roundish cells).
1.6 Amelanotic Melanoma
The diagnosis of amelanotic melanoma is clinically challenging (Fig. 14.5a). Confusions with benign skin lesions or nonmelanoma skin cancer are potential pitfalls. Dermoscopic evaluation is useful to detect subtle signs of amelanotic melanoma, such as the presence of dotted vessels, linear irregular vessels, and milky red areas (Fig. 14.5b) [32, 33]. Amelanotic lesions are a major indication for RCM, as even small amounts of melanin can be seen with RCM [20]. RCM findings in amelanotic melanoma are similar to pigmented melanoma and include the proliferation of polymorphic large cells in the epidermis, DEJ (Fig. 14.5c, d) and dermis, loss of normal honeycomb pattern in the suprabasal epidermis, and DEJ disarray with irregular dermal papillae [34]. Pagetoid cells may appear dendritic or roundish. Unlike the hyper-reflective atypical cells of pigmented melanomas, melanocytes of amelanotic or hypomelanotic melanomas are hypo-reflective because of the lack of melanin and may appear as dark holes in the epidermis [35].
1.7 RCM Diagnostic Algorithms for Melanoma Diagnosis
Five main scoring systems and algorithms have been developed for the diagnosis of melanoma using RCM [1, 20, 36,37,38,39,40,41].
-
The Modena algorithm: Pellacani et al. identified six RCM criteria that independently correlate with the diagnosis of melanoma and may be used to differentiate melanomas from nevi [42, 43]. The scoring algorithm is composed of two major criteria (two points each) and four minor criteria (one point each). A score greater than or equal to 3 is strongly associated with the diagnosis of melanoma (97.3% sensitivity and 72.3% specificity).
-
The major criteria (+2 points per feature) are:
-
Non-edged dermal papillae
-
Atypical cells at the DEJ
-
-
The minor criteria (+1 point per feature) are:
-
Roundish pagetoid cells
-
Pagetoid cells widespread throughout the lesion
-
Cerebriform clusters in the papillary dermis
-
Isolated nucleated cells within dermal papilla
-
-
-
The Barcelona algorithm: Segura et al. [37] developed a two-step method for differentiating melanocytic from nonmelanocytic lesions and melanoma from nevi using RCM.
-
The two steps are:
-
Step 1: to determine if the lesion is melanocytic or nonmelanocytic. A melanocytic lesion is suspected based on the presence of at least one of four RCM features. Features of a melanocytic lesion include cobblestone pattern, pagetoid spread, meshwork appearance at DEJ and presence of dermal clusters of cells or dermal nests.
-
Step 2: to determine if the lesion is a nevus or a melanoma using a scoring system. Benign features (absence of basal cell atypia and edged papillae) are given a score of −1, while malignant features (roundish pagetoid cells and atypical dermal nucleated cells) a score of +1. Lesions with a score greater than or equal to −1 have a sensitivity and specificity, respectively, of 86.1 and 95.3%, for melanoma. However, with this threshold there were five false-negative results in their study, including four in situ and one SSM, indicating the possible limitation of the algorithm in thin melanoma. A score greater than or equal to −2 had an increased sensitivity of 100% but specificity reduced to 57%. The authors calculated that, despite a lower specificity, half of biopsies could be avoided, without missing a melanoma.
-
-
-
Guitera et al. [36] described a two-step method to diagnose melanoma and basal cell carcinoma (BCC). Independently significant RCM features were identified to establish the following criteria in a two-step algorithm. The first step is to determine if the lesion is a BCC by the analysis of positive and negative features.
-
The second step is to determine if the lesion is a melanoma using the Modena algorithm.
-
Borsari et al. [41] recently proposed a diagnostic score for melanoma in situ (MIS) combining dermoscopic and RCM features. Dermoscopic finding of atypical pigment network and regression gives 1 point each. On RCM, the observation of pagetoid cells gives 1 point and cytologic atypia 1 point if it is focal and 1 points if it is widespread. The presence of dense nests and melanophages was found to be protective of MIS and given −1 point each.
-
Guitera et al. [20] developed the LM score to assist in differentiating LM from equivocal pigmented macules of the face. Six features that independently correlate with the diagnosis of LM were identified. The score consists of two major and four minor criteria. With a score more than or equal to 2 points, a sensitivity and specificity of 85 and 76%, respectively (odds ratio: 18.6; 95% CI: 9.3–37.1), were achieved for LM diagnosis. The major criteria are: non-edged dermal papillae (+2) and large round pagetoid cells (+2). The minor criteria are: nucleated cells in the dermal papillae (+1), atypical cells at the DEJ (+1), adnexal spread of atypical cells (+1), and broadened honeycomb pattern (−1).
1.8 Clinical Application of RCM for LM/LMM
Among all melanoma subtypes, RCM is most applicable to the management of LM and LMM due to the radial growth of this neoplasia and the limited depth penetration of RCM. Moreover, noninvasive diagnosis and identification of surgical margins are particularly important for LM/LMM because this melanoma is mainly located on esthetic and functional areas such as the face, and it may have subclinical extension.
1.9 Guide for Biopsies
LM/LMM often has a large surface, and a single biopsy could miss the area with the typical histological features. RCM may be used to assist in targeting the area for incisional biopsy to the most suspicious area for a correct diagnosis and for assessing the level of invasion [44].
1.10 Preoperative Mapping
LM/LMM has the highest risk of residual disease and highest recurrence rate of all melanoma subtypes after surgical excision [45]. RCM may allow the identification of subclinical cancer invasion [25, 46]. Presurgical mapping of the suspicious area helps surgeons planning the surgery and the eventual reconstruction. It has been used successfully intraoperatively to achieve negative surgical margins in a case of standard excision [47] and also in combination with the staged excision spaghetti technique [48, 49]. Margin delineation of LM and LMM with the handheld RCM (HRCM) could be limited by the lack of precise orientation during imaging and the small field of view in the absence of mosaics. Video mosaicking of HRCM images is a novel technique developed to overcome this limitation [50].
1.11 Monitoring of Nonsurgical Therapies
RCM can be used to assess response to treatment of LM/LMM and allow detection of treatment failure with better diagnostic accuracy than dermoscopy, especially after nonsurgical treatments (e.g., radiation therapy or topical imiquimod) [51, 52]. An advantage of RCM is that it enables the clinician to follow difficult cases with serial noninvasive “virtual biopsies” of the skin.
References
Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal microscopy of pigmented skin lesions–improvement in melanoma diagnostic specificity. J Am Acad Dermatol. 2005;53:979–85.
Rajadhyaksha M, González S, Zavislan JM, Rox Anderson R, Webb RH. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with Histology11The authors have declared conflict of interest. J Investig Dermatol. 1999;113:293–303.
Longo C, et al. Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases. Br J Dermatol. 2013;169:58–67.
Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol. 1995;104:946–52.
Yamashita T, Kuwahara T, González S, Takahashi M. Non-invasive visualization of melanin and melanocytes by reflectance-mode confocal microscopy. J Investig Dermatol. 2005;124:235–40.
Stanganelli I, et al. Integration of reflectance confocal microscopy in sequential dermoscopy follow-up improves melanoma detection accuracy. Br J Dermatol. 2015;172:365–71.
Ferrari B, et al. Dermoscopic difficult lesions: an objective evaluation of reflectance confocal microscopy impact for accurate diagnosis. J Eur Acad Dermatol Venereol. 2015;29:1135–40.
Alarcon I, et al. Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions. Br J Dermatol. 2014;170:802–8.
Pellacani G, Pepe P, Casari A, Longo C. Reflectance confocal microscopy as a second-level examination in skin oncology improves diagnostic accuracy and saves unnecessary excisions: a longitudinal prospective study. Br J Dermatol. 2014;171:1044–51.
Guitera P, et al. In vivo reflectance confocal microscopy enhances secondary evaluation of melanocytic lesions. J Investig Dermatol. 2009;129:131–8.
Pellacani G, et al. Cost-benefit of reflectance confocal microscopy in the diagnostic performance of melanoma. J Eur Acad Dermatol Venereol. 2016;30:413–9.
Waddell A, Star P, Guitera P. Advances in the use of reflectance confocal microscopy in melanoma. Melanoma Management. 2018;5:MMT04.
Longo C, Pellacani G. Melanomas. Dermatol Clin. 2016;34:411–9.
Cicchiello M, Lin MJ, Pan Y, McLean C, Kelly JW. An assessment of clinical pathways and missed opportunities for the diagnosis of nodular melanoma versus superficial spreading melanoma: pathways for diagnosis of NM versus SSM. Australas J Dermatol. 2016;57:97–101.
Moloney FJ, Menzies SW. Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma: Dermoscopy of amelanotic and nodular melanoma. J Dermatol. 2011;38:10–5.
Segura S, et al. In vivo microscopic features of nodular melanomas: dermoscopy, confocal microscopy, and Histopathologic correlates. Arch Dermatol. 2008;144(10):1311–20.
Lallas A, et al. Diagnosis and management of facial pigmented macules. Clin Dermatol. 2014;32:94–100.
Cinotti E, et al. Dermoscopy vs. reflectance confocal microscopy for the diagnosis of lentigo maligna. J Eur Acad Dermatol Venereol. 2018;32:1284–91.
Star P, Guitera P. Lentigo Maligna, macules of the face, and lesions on sun-damaged skin. Dermatol Clin. 2016;34:421–9.
Guitera P, et al. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of Lentigo Maligna and equivocal pigmented and nonpigmented macules of the face. J Investig Dermatol. 2010;130:2080–91.
Langley RGB, Burton E, Walsh N, Propperova I, Murray SJ. In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna. J Am Acad Dermatol. 2006;55:88–97.
Ahlgrimm-Siess V, et al. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study. Br J Dermatol. 2009;161:1307–16.
Tannous ZS, Mihm MC, Flotte TJ, González S. In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections. J Am Acad Dermatol. 2002;46:260–3.
Guitera P, et al. Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. Br J Dermatol. 2014;170:1305–12.
Guitera P, et al. Improving management and patient Care in Lentigo Maligna by mapping with in vivo confocal microscopy. JAMA Dermatol. 2013;149:692.
Reed JA, Shea CR. Lentigo maligna: melanoma in situ on chronically sun-damaged skin. Arch Pathol Lab Med. 2011;135:838–41.
Phan A, et al. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol. 2007;157:311–8.
Cinotti E, et al. Reflectance confocal microscopy features of acral lentiginous melanoma: a comparative study with acral nevi. J Eur Acad Dermatol Venereol. 2016;30:1125–8.
LeBoit PE. A diagnosis for maniacs. Am J Dermatopathol. 2000;22:556–8.
Saida T, Koga H, Goto Y, Uhara H. Characteristic distribution of melanin columns in the cornified layer of acquired acral nevus: an important clue for histopathologic differentiation from early acral melanoma. Am J Dermatopathol. 2011;33:468–73.
Chen LL, Jaimes N, Barker CA, Busam KJ, Marghoob AA. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68:825–33.
Pizzichetta MA, et al. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol. 2004;150:1117–24.
Menzies SW, et al. Dermoscopic evaluation of Amelanotic and Hypomelanotic melanoma. Arch Dermatol. 2008;144(9):1120–7.
Gill M, González S. Enlightening the Pink Dermatologic Clinics. 2016;34:443–58.
Losi A, et al. Hyporeflective pagetoid cells: a new clue for amelanotic melanoma diagnosis by reflectance confocal microscopy. Br J Dermatol. 2014;171:48–54.
Guitera P, et al. In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases. J Investig Dermatol. 2012;132:2386–94.
Segura S, Puig S, Carrera C, Palou J, Malvehy J. Development of a two-step method for the diagnosis of melanoma by reflectance confocal microscopy. J Am Acad Dermatol. 2009;61:216–29.
Langley RGB, et al. The diagnostic accuracy of in vivo confocal scanning laser microscopy compared to Dermoscopy of benign and malignant melanocytic lesions: a prospective study. Dermatology. 2007;215:365–72.
Gerger A, et al. Diagnostic image analysis of malignant melanoma in in vivo confocal laser-scanning microscopy: a preliminary study. Skin Res Technol. 2008;14:359–63.
Gerger A, et al. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer. 2006;107:193–200.
Borsari S, et al. In vivo dermoscopic and confocal microscopy multistep algorithm to detect in situ melanomas. Br J Dermatol. 2018;179:163–72.
Pellacani G, et al. The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. J Invest Dermatol. 2007;127:2759–65.
Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal microscopy for the in vivo characterization of pagetoid melanocytosis in melanomas and nevi. J Invest Dermatol. 2005;125:532–7.
Hibler BP, et al. Handheld reflectance confocal microscopy to aid in the management of complex facial lentigo maligna. Cutis. 2017;99:346–52.
Bolshinsky V, et al. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy. J Am Acad Dermatol. 2016;74:102–7.
Chen C-SJ, Elias M, Busam K, Rajadhyaksha M, Marghoob AA. Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. Br J Dermatol. 2005;153:1031–6.
Hibler BP, Cordova M, Wong RJ, Rossi AM. Intraoperative real-time reflectance confocal microscopy for guiding surgical margins of lentigo maligna melanoma. Dermatol Surg. 2015;41:980–3.
Champin J, et al. In vivo reflectance confocal microscopy to optimize the spaghetti technique for defining surgical margins of Lentigo Maligna. Dermatol Surg. 2014;40:247–56.
Couty E, et al. In vivo reflectance confocal microscopy combined with the ‘spaghetti technique’ for the identification of surgical margins of lentigo maligna: experience in 70 patients. J Eur Acad Dermatol Venereol. 2018;32:e366–8.
Kose K, et al. Video-mosaicing of reflectance confocal images for examination of extended areas of skin in vivo. Br J Dermatol. 2014;171:1239–41.
Nadiminti H, Scope A, Marghoob AA, Busam K, Nehal KS. Use of reflectance confocal microscopy to monitor response of Lentigo Maligna to nonsurgical treatment. Dermatol Surg. 2010;36:177–84.
Alarcon I, et al. In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod. J Am Acad Dermatol. 2014;71:49–55.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Campoli, M., Perrot, J.L., Cinotti, E. (2020). In Vivo Reflectance Confocal Microscopy for Melanoma. In: Fimiani, M., Rubegni, P., Cinotti, E. (eds) Technology in Practical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-45351-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-45351-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45350-3
Online ISBN: 978-3-030-45351-0
eBook Packages: MedicineMedicine (R0)